Skip to content

Clinical trials

Pathologic Complete Response trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Complete Response Status: Unknown status Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20123
20132
20141
20151
20171
20182
20191
20207
20211
20224
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sixth Affiliated Hospital, Sun Yat-sen University2
Barwon Health1
Centre Leon Berard1
Changchun Intellicrown Pharmaceutical Co. LTD1
Chinese Academy of Medical Sciences1
Coronado Biosciences, Inc.1
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Guangdong Provincial People's Hospital1
Instituto Brasileiro de Controle do Cancer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Complete Response27
Breast Neoplasms9
Rectal Neoplasms5
Triple Negative Breast Neoplasms3
Esophageal Squamous Cell Carcinoma2
Leukemia, Myeloid, Acute2
COVID-191
Carcinoma, Non-Small-Cell Lung1
Esophageal Neoplasms1
Hereditary Sensory and Autonomic Neuropathies1

Trials

Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.